ANXA1 and chronic obstructive pulmonary disease: The interrelation between AnxA1, sRAGE and COPD could be explained through their effects on inflammatory mediator pathways, including through GSH and MDA levels, which affect the release of inflammatory factors and, subsequently, lung injury.